Neuroprotective role of estrogens: Relationship with insulin/IGF-1 signaling

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 2, 2012, Pages 607-619

  Alonso, Ana ^a   Gonzalez, Celestino ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Aging; Estrogen; Insulin; Review

Indexed keywords

ESTRADIOL; ESTROGEN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; ARTICLE; BASIC RESEARCH; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DETERIORATION; ESTROGEN THERAPY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PALLIATIVE THERAPY; POSTMENOPAUSE; PROMOTER REGION; QUALITY OF LIFE; SIGNAL TRANSDUCTION; BRAIN; METABOLISM; PHYSIOLOGY; REVIEW;

BRAIN; ESTROGENS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 84860855755     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (137)

1. C. R. Park, R. J. Seeley, S. Craft and S. C. Woods: Intracerebroventricular insulin enhances memory in a passive-avoidance task. PhysiolBehav 68, 509-514 (2000)
2. C. R. Park: Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25, 311-323 (2001)
3. G. Winocur and S. Gagnon: Glucose treatment attenuates spatial learning and memory deficits of aged rats on tests of hippocampal function. Neurobiol Aging 19, 233-241 (1998)
4. K. M. Dhandapani and D. W. Brann: Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 67, 1379-1385 (2002)
5. L. M. Garcia-Segura, I. Azcoitia and L. L. DonCarlos: Neuroprotection by estradiol. Prog Neurobiol 63, 29-60 (2001)
6. A. Alonso, M. Moreno, P. Ordonez, R. Fernandez, C. Perez, F. Diaz, A. Navarro, J. Tolivia and C. Gonzalez: Chronic estradiol treatment improves brain homeostasis during aging in female rats. Endocrinology 149, 57-72 (2008)
7. G. P. Cardona-Gomez, P. Mendez, L. L. DonCarlos, I. Azcoitia and L. M. Garcia-Segura: Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 37, 320-334 (2001)
8. G. P. Cardona-Gomez, P. Mendez and L. M. Garcia-Segura: Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Brain Res Mol Brain Res 107, 80-88 (2002)
9. D. Davila, J. Piriz, J. L. Trejo, A. Nunez and I. Torres- Aleman: Insulin and insulin-like growth factor I signaling in neurons. Front Biosci 12:3194-202., 3194-3202 (2007)
10. J. Piriz, A. Muller, J. L. Trejo and I. Torres-Aleman: IGF-I and the aging mammalian brain. Exp Gerontol (2010)
11. W. E. Sonntag, M. Ramsey and C. S. Carter: Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 4, 195-212 (2005)
12. S. C. Woods, R. J. Seeley, D. G. Baskin and M. W. Schwartz: Insulin and the blood-brain barrier. Curr Pharm Des 9, 795-800 (2003)
13. S. U. Devaskar, S. J. Giddings, P. A. Rajakumar, L. R. Carnaghi, R. K. Menon and D. S. Zahm: Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269, 8445-8454 (1994)
14. W. A. Banks, J. B. Jaspan and A. J. Kastin: Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 18, 1577-1584 (1997)
15. K. J. Kaiyala, R. L. Prigeon, S. E. Kahn, S. C. Woods and M. W. Schwartz: Obesity induced by a highfat diet is associated with reduced brain insulin transport in dogs. Diabetes 49, 1525-1533 (2000)
16. J. Havrankova, J. Roth and M. Brownstein: Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272, 827-829 (1978)
17. J. L. Marks, D. Porte, Jr., W. L. Stahl and D. G. Baskin: Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127, 3234-3236 (1990)
18. G. A. Werther, A. Hogg, B. J. Oldfield, M. J. McKinley, R. Figdor, A. M. Allen and F. A. Mendelsohn: Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 121, 1562-1570 (1987)
19. M. Schubert, D. Gautam, D. Surjo, K. Ueki, S. Baudler, D. Schubert, T. Kondo, J. Alber, N. Galldiks, E. Kustermann, S. Arndt, A. H. Jacobs, W. Krone, C. R. Kahn and J. C. Bruning: Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 101, 3100-3105 (2004)
20. L. P. van der Heide, G. M. Ramakers and M. P. Smidt: Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 79, 205-221 (2006)
21. W. Q. Zhao, H. Chen, M. J. Quon and D. L. Alkon: Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 490, 71-81 (2004)
22. S.B.Biddinger and C.R. Kahn. From mice to men: insights into the insulin resistance syndromes Annu Rev Physiol 68, 123-158, (2006)
23. R. Duelli and W. Kuschinsky: Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16, 71-76 (2001)
24. S. El Messari, C. Leloup, M. Quignon, M. J. Brisorgueil, L. Penicaud and M. Arluison: Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neurol 399, 492-512 (1998)
25. W. M. Pardridge: Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann N Y Acad Sci 692:126-37., 126-137 (1993)
26. R. Slaaby, L. Schaffer, I. Lautrup-Larsen, A. S. Andersen, A. C. Shaw, I. S. Mathiasen and J. Brandt: Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J Biol Chem 281, 25869-25874 (2006)
27. C. E. Greenwood and G. Winocur: Glucose treatment reduces memory deficits in young adult rats fed high-fat diets. Neurobiol Learn Mem 75, 179-189 (2001)
28. C. Messier, M. Gagnon and V. Knott: Effect of glucose and peripheral glucose regulation on memory in the elderly. Neurobiol Aging 18, 297-304 (1997)
29. W. Kern, A. Peters, B. Fruehwald-Schultes, E. Deininger, J. Born and H. L. Fehm: Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 74, 270-280 (2001)
30. I. G. Onyango and S. M. Khan: Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. Curr Alzheimer Res 3, 339-349 (2006)
31. A. Ott, R. P. Stolk, F. van Harskamp, H. A. Pols, A. Hofman and M. M. Breteler: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937-1942 (1999)
32. R. P. Stolk, M. M. Breteler, A. Ott, H. A. Pols, S. W. Lamberts, D. E. Grobbee and A. Hofman: Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 20, 792-795 (1997)
33. R. P. Stolk, H. A. Pols, S. W. Lamberts, P. T. de Jong, A. Hofman and D. E. Grobbee: Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. Am J Epidemiol 145, 24-32 (1997)
34. S. M. de la Monte, M. Tong, N. Lester-Coll, M. Plater, Jr. and J. R. Wands: Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimer Dis 10, 89-109 (2006)
35. M. L. Fernandes, M. J. Saad and L. A. Velloso: Effects of age on elements of insulin-signaling pathway in central nervous system of rats. Endocrine 16, 227-234 (2001)
36. S. Craft and G. S. Watson: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3, 169-178 (2004)
37. M. A. Smith, L. M. Sayre, V. M. Monnier and G. Perry: Radical ageing in Alzheimer's disease. Trends Neurosci 18, 172-176 (1995)
38. L. Gasparini and H. Xu: Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 26, 404-406 (2003)
39. Y. Ling, K. Morgan and N. Kalsheker: Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int J Biochem Cell Biol 35, 1505-1535 (2003)
40. D. Edbauer, M. Willem, S. Lammich, H. Steiner and C. Haass: Insulin-degrading enzyme rapidly removes the betaamyloid precursor protein intracellular domain (AICD). J Biol Chem 277, 13389-13393 (2002)
41. S. Craft, S. Asthana, D. G. Cook, L. D. Baker, M. Cherrier, K. Purganan, C. Wait, A. Petrova, S. Latendresse, G. S. Watson, J. W. Newcomer, G. D. Schellenberg and A. J. Krohn: Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28, 809-822 (2003)
42. J. W. Simpkins, M. Singh and J. Bishop: The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15 Suppl 2, S195-S197 (1994)
43. J. A. Tsiouris: Metabolic depression in hibernation and major depression: an explanatory theory and an animal model of depression. Med Hypotheses 65, 829-840 (2005)
44. Y. C. Choi, J. H. Lee, K. W. Hong and K. S. Lee: 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam Clin Pharmacol 18, 547-557 (2004)
45. D. A. Pelligrino, R. Santizo, V. L. Baughman and Q. Wang: Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport 9, 3285-3291 (1998)
46. A. P. Raval, A. Bhatt and I. Saul: Chronic nicotine exposure inhibits 17beta-estradiol-mediated protection of the hippocampal CA1 region against cerebral ischemia in female rats. Neurosci Lett 458, 65-69 (2009)
47. I. Soderstrom, M. Strand, A. C. Ingridsson, S. Nasic and T. Olsson: 17beta-estradiol and enriched environment accelerate cognitive recovery after focal brain ischemia. Eur J Neurosci 29, 1215-1224 (2009)
48. J. O. Strom, A. Theodorsson and E. Theodorsson: Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. J Cereb Blood Flow Metab 29, 1359-1372 (2009)
49. C. K. Won, H. H. Ji and P. O. Koh: Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci Lett 398, 39-43 (2006)
50. de Lecinana Alonso and J. A. Egido: Estrogens as neuroprotectants against ischemic stroke. Cerebrovasc Dis 21 Suppl 2, 48-53 (2006)
51. D. Amantea, R. Russo, G. Bagetta and M. T. Corasaniti: From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 52, 119-132 (2005)
52. M. Kajta and C. Beyer: Cellular strategies of estrogenmediated neuroprotection during brain development. Endocrine 21, 3-9 (2003)
53. L. D. McCullough and P. D. Hurn: Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 14, 228-235 (2003)
54. P. M. Wise, D. B. Dubal, M. E. Wilson, S. W. Rau and M. Bottner: Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 142, 969-973 (2001)
55. S. W. Rau, D. B. Dubal, M. Bottner, L. M. Gerhold and P. M. Wise: Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci 23, 11420-11426 (2003)
56. N. J. Alkayed, S. Goto, N. Sugo, H. D. Joh, J. Klaus, B. J. Crain, O. Bernard, R. J. Traystman and P. D. Hurn: Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci 21, 7543-7550 (2001)
57. D. B. Dubal, P. J. Shughrue, M. E. Wilson, I. Merchenthaler and P. M. Wise: Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 19, 6385-6393 (1999)
58. C. K. Won, M. O. Kim and P. O. Koh: Estrogen modulates Bcl-2 family proteins in ischemic brain injury. J Vet Med Sci 68, 277-280 (2006)
59. R. Zhang, Y. Y. Xue, S. D. Lu, Y. Wang, L. M. Zhang, Y. L. Huang, A. P. Signore, J. Chen and F. Y. Sun: Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiol Dis 24, 345-356 (2006)
60. M. D'Astous, P. Mendez, M. Morissette, L. M. Garcia-Segura and T. Di Paolo: Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol Pharmacol 69, 1492-1498 (2006)
61. P. Mendez, I. Azcoitia and L. M. Garcia-Segura: Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res 112, 170-176 (2003)
62. M. E. Wilson, K. L. Rosewell, M. L. Kashon, P. J. Shughrue, I. Merchenthaler and P. M. Wise: Age differentially influences estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) gene expression in specific regions of the rat brain. Mech Ageing Dev 123, 593-601 (2002)
63. D. B. Dubal, H. Zhu, J. Yu, S. W. Rau, P. J. Shughrue, I. Merchenthaler, M. S. Kindy and P. M. Wise: Estrogen receptor alpha, not beta, is a critical link in estradiolmediated protection against brain injury. Proc Natl Acad Sci U S A 98, 1952-1957 (2001)
64. K. Sampei, S. Goto, N. J. Alkayed, B. J. Crain, K. S. Korach, R. J. Traystman, G. E. Demas, R. J. Nelson and P. D. Hurn: Stroke in estrogen receptor-alpha-deficient mice. Stroke 31, 738-743 (2000)
65. A. A. Ardelt, L. D. McCullough, K. S. Korach, M. M. Wang, D. H. Munzenmaier and P. D. Hurn: Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke 36, 337-341 (2005)
66. R. D. Brinton: A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health. Int J Fertil Womens Med 44, 174-185 (1999)
67. R. D. Brinton: Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem 8, 121-133 (2001)
68. P. S. Green and J. W. Simpkins: Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18, 347-358 (2000)
69. B. S. McEwen, S. E. Alves, K. Bulloch and N. G. Weiland: Ovarian steroids and the brain: implications for cognition and aging. Neurology 48, S8-15 (1997)
70. B. S. McEwen: Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 91, 2785-2801 (2001)
71. G. Mor, J. Nilsen, T. Horvath, I. Bechmann, S. Brown, L. M. Garcia-Segura and F. Naftolin: Estrogen and microglia: A regulatory system that affects the brain. J Neurobiol 40, 484-496 (1999)
72. J. Nilsen and R. D. Brinton: Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143, 205-212 (2002)
73. J. Nilsen and R.D.Brinton: Mechanism of estrogenmediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci U S A 100, 2842-2847 (2003)
74. M. Singh, E. M. Meyer, W. J. Millard and J. W. Simpkins: Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644, 305-312 (1994)
75. C. S. Woolley: Effects of estrogen in the CNS. Curr Opin Neurobiol 9, 349-354 (1999)
76. L.M. Garcia-Segura: Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol 20(6), 705-712, (2008)
77. C.A.Cornil and T.D.Charlier: Rapid behavioural effects of oestrogens and fast regulation of their local synthesis by brain aromatase. J Neuroendocrinol 22(7), 664-673, (2010)
78. S.A. Shumaker, C.Legault, S.R. Rapp, L.Thal, R.B. Wallace, J.K. Ockene, S.L. Hendrix, B.N. Jones3rd, A.R.Assaf, R.D. Jackson, J.M.Kotchen, S.Wassertheil-Smoller, J.Wactawski-Wende; WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289(20), 2651-2662, (2003)
79. R. T. Hamilton, J. R. Rettberg, Z. Mao, J. To, L. Zhao, S. E. Appt, T.C. Register, J. R. Kaplan, R. DiazBrinton: Hippocampal responsiveness to 17β-estradiol and equol after long-term ovariectomy: Implication for a therapeutic window of opportunity. Brain Research doi:10.1016/j.brainres.2011. 01.029
80. A. Migliaccio, M. Di Domenico, G. Castoria, A. de Falco, P. Bontempo, E. Nola and F. Auricchio: Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiolreceptor complex in MCF-7 cells. EMBO J 15(6), 1292-300 (1996)
81. .C.A. Singer, X.A. Figueroa-Masot, R.H. Batchelor and D.M. Dorsa: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19(7), 2455-63 (1999)
82. G. Castoria, M.V. Barone, M. Di Domenico, A. Bilancio, D. Ametrano, A. Migliaccio and F. Auricchio: Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 18(9), 2500-10 (1999)
83. M. Singh, G. Setalo, Jr., X. Guan, M. Warren and C. D. Toran-Allerand: Estrogen-induced activation of mitogenactivated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19, 1179-1188 (1999)
84. C. J. Marshall: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signalregulated kinase activation. Cell 80, 179-185 (1995)
85. R. Marin, B. Guerra, R. Alonso, C.M. Ramírez, M. Díaz: Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res 2(4), 287-301, (2005)
86. D. N. Bryant, A. Bosch, K. Rønnekleiv and D. M. Dorsaa: 17-β estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 133, 343-352 (2005)
87. R. Marin, C. Ramírez, A. Morales, M. González, R. Alonso and M. Díaz: Modulation of Abeta-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts. Steroids 73(9-10), 992-6 (2008)
88. C.M. Ramírez, M. González, M. Díaz, R. Alonso, I. Ferrer, G. Santpere, B. Puig, G. Meyer, R. Marin: VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease. Mol Cell Neurosci 42(3), 172-83 (2009)
89. Z. L. Tang, P. E. Scherer and M. P. Lisanti: The primary sequence of murine caveolin reveals a conserved consensus site for phosphorylation by protein kinase C. Gene 147, 299-300 (1994)
90. C. Mineo, R. G. Anderson and M. A. White: Physical association with ras enhances activation of membrane-bound raf (RafCAAX). J Biol Chem 272, 10345-10348 (1997)
91. S. R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh and M. E. Greenberg: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (1997)
92. R. Nilsen J. Irwin R. W. Brinton R. D. Masri:Estradiol-mediated mitochondrial regulation and neuroprotection. Soc Neurosci abstract 659.4 (2004)
93. J. Nilsen and R. D. Brinton: Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 3, 297-313 (2004)
94. A. Alonso, R. Fernandez, P. Ordonez, M. Moreno, A. M. Patterson and C. Gonzalez: Regulation of estrogen receptor alpha by estradiol in pregnant and estradiol treated rats. Steroids 71, 1052-1061 (2006)
95. G. Flouriot, H. Brand, S. Denger, R. Metivier, M. Kos, G. Reid, V. Sonntag-Buck and F. Gannon: Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 19, 4688-4700 (2000)
96. R. Marin, B. Guerra, A. Morales, M. Diaz and R. Alonso: An oestrogen membrane receptor participates in estradiol actions for the prevention of amyloid-beta peptide1-40-induced toxicity in septal-derived cholinergic SN56 cells. J Neurochem 85, 1180-1189 (2003)
97. A. M. Norfleet, C. H. Clarke, B. Gametchu and C. S. Watson: Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J 14, 157-165 (2000)
98. S. B. Pedersen, J. M. Bruun, F. Hube, K. Kristensen, H. Hauner and B. Richelsen: Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 182, 27-37 (2001)
99. P. Cardona-Gomez, M. Perez, J. Avila, L. M. Garcia-Segura and F. Wandosell: Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and betacatenin in the hippocampus. Mol Cell Neurosci 25, 363-373 (2004)
100. V. Znamensky, K. T. Akama, B. S. McEwen and T. A. Milner: Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci 23, 2340-2347 (2003)
101. N. Rasgon and L. Jarvik: Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol A Biol Sci Med Sci 59, 178-183 (2004)
102. A. L. Markowska, M. Mooney and W. E. Sonntag: Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience 87, 559-569 (1998)
103. C. D. Lynch, D. Lyons, A. Khan, S. A. Bennett and W. E. Sonntag: Insulin-like growth factor-1 selectively increases glucose utilization in brains of aged animals. Endocrinology 142, 506-509 (2001)
104. M. Duenas, S. Luquin, J. A. Chowen, I. Torres-Aleman, F. Naftolin and L. M. Garcia-Segura: Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rats. Neuroendocrinology 59, 528-538 (1994)
105. N. K. El Bakri, A. Islam, I. Suliman, U. Lindgren, B. Winblad and A. Adem: Ovariectomy and gonadal hormone treatment: effects on insulin-like growth factor-1 receptors in the rat brain. Growth Horm IGF Res 14, 388-393 (2004)
106. G. P. Cardona-Gomez, J. L. Trejo, A. M. Fernandez and L. M. Garcia-Segura: Estrogen receptors and insulinlike growth factor-I receptors mediate estrogen-dependent synaptic plasticity. Neuroreport 11, 1735-1738 (2000)
107. K. Honda, H. Sawada, T. Kihara, M. Urushitani, T. Nakamizo, A. Akaike and S. Shimohama: Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 60, 321-327 (2000)
108. S. Kahlert, S. Nuedling, M. van Eickels, H. Vetter, R. Meyer and C. Grohe: Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275, 18447-18453 (2000)
109. C. J. Mullonkal and L. H. Toledo-Pereyra: Akt in ischemia and reperfusion. J Invest Surg 20, 195-203 (2007)
110. H. Zhao, R. M. Sapolsky and G. K. Steinberg: Phosphoinositide-3-kinase/ Akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34, 249-270 (2006)
111. D. R. Kaplan and F. D. Miller: Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10, 381-391 (2000)
112. R. D. Almeida, B. J. Manadas, C. V. Melo, J. R. Gomes, C. S. Mendes, M. M. Graos, R. F. Carvalho, A. P. Carvalho and C. B. Duarte: Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12, 1329-1343 (2005)
113. M. Encinas, M. Iglesias, N. Llecha and J. X. Comella: Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factormediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 73, 1409-1421 (1999)
114. N. Nguyen, S. B. Lee, Y. S. Lee, K. H. Lee and J. Y. Ahn: Neuroprotection by NGF and BDNF against neurotoxinexerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 34, 942-951 (2009)
115. G. P. Cardona-Gomez, L. DonCarlos and L. M. Garcia-Segura: Insulin-like growth factor I receptors and estrogen receptors colocalize in female rat brain. Neuroscience 99, 751-760 (2000)
116. L. M. Garcia-Segura, G. P. Cardona-Gomez, J. A. Chowen and I. Azcoitia: Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection. J Neurocytol 29, 425-437 (2000)
117. I. Azcoitia, A. Moreno, P. Carrero, S. Palacios and L. M. Garcia-Segura: Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecol Endocrinol 22, 63-69 (2006)
118. C. D. Toran-Allerand, M. Singh and G. Setalo, Jr.: Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol 20, 97-121 (1999)
119. P. Mendez, I. Azcoitia and L. M. Garcia-Segura: Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analyzing neuroprotective mechanisms. J Endocrinol 185, 11-17 (2005)
120. S. Lovestone, C. H. Reynolds, D. Latimer, D. R. Davis, B. H. Anderton, J. M. Gallo, D. Hanger, S. Mulot, B. Marquardt, and S. Stabel: Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4, 1077-1086 (1994)
121. D. A. Cross, D. R. Alessi, P. Cohen, M. Andjelkovich and B. A. Hemmings: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995)
122. A. Brunet, A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis and M. E. Greenberg: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999)
123. G. J. Kops, N. D. de Ruiter, A. M. De Vries-Smits, D. R. Powell, J. L. Bos and B. M. Burgering: Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630-634 (1999)
124. E. D. Tang, G. Nunez, F. G. Barr and K. L. Guan: Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274, 16741-16746 (1999)
125. L.del Peso, M. Gonzalez-Garcia, C. Page, R. Herrera and G. Nunez: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689 (1997)
126. S.W. Lamberts, A.W. van derBeld, and A.J. van der Lely: The endocrinology of aging. Science 278(5337), 419-24 (1997)
127. I. Azcoitia, L.L. DonCarlos and L.M. Garcia-Segura: Are gonadal steroid hormones involved in disorders of brain aging? Aging Cell 2(1), 31-7 (2003)
128. W.E. Sonntag, M. Ramsey and C.S. Carter: Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 4(2), 195-212 (2005)
129. F.Grodstein, M.J.Stampfer, J.E. Manson, G.A.Colditz, W.C. Willett, B.Rosner, F.E.Speizer and C.H. Hennekens: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335(7), 453-461 (1996)
130. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. Ockene: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288(3), 321-33 (2002)
131. L.M. Garcia-Segura, Y. Diaz-Chaves, M. Perez- Martin, M. Darnaudéry: Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology32 Suppl 1, S57-61 (2007)
132. M. L. Traub, M. De Butte-Smith, P, R. S. Zukin, and A. M. Etgen:Oestradiol and IGF1 reduce cell loss after global ischemia in middle-aged female rats. J Neuroendocrinol 21(12), 1038-1044 (2009)
133. M. Bondanelli, M.R. Ambrosio, A. Onofri, A. Bergonzoni, S. Lavezzi, M.C. Zatelli, D. Valle, N. Basaglia, E.C. degliUberti: Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab 91(10), 3928-3934 (2006)
134. .L. Denti, V. Annoni, E. Cattadori, M.A. Salvagnini, S. Visioli, M.F. Merli, F. Corradi, G. Ceresini, G. Valenti, A.R. Hoffman, G.P. Ceda: Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 117(5), 312-317 (2004)
135. E.J. Sorenson, A.J. Windbank, J.N. Mandrekar, W.R. Bamlet, S.H. Appel, C. Armon, P.E. Barkhaus, P. Bosch, K. Boylan, W.S. David, E. Feldman, J. Glass, L. Gutmann, J. Katz, W. King, C.A. Luciano, L.F. McCluskey, S. Nash, D.S. Newman, R.M. Pascuzzi, E. Pioro, L.J. Sams, S. Scelsa, E.P. Simpson, S.H. Subramony, E.Tiryaki, C.A. Thornton: Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71(22), 1770-1775 (2008)
136. L.R. Hanson and W.H. Frey: Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci S5, (2008)
137. L. Fletcher, S. Kohli, S.M. Sprague, R.A. Scranton, S.A. Lipton, A. Parra, D.F. Jimenez, M.Digicaylioglu: Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. J Neurosurg 111, 164-70 (2009)